How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code DYF: Prosthesis, Vascular Graft, Of Less Then 6mm Diameter. View classification details, related manufacturers, 510(k) clearances, and recall records.
21 clearance records and 17 recall records in the covered releases, across 7 source company names and 1 product codes. Dated history runs from Oct 9, 1979 to May 3, 2024.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| DYF · Prosthesis, Vascular Graft, Of Less Then 6mm Diameter | 21 | 17 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| ADVANTA VXT, 5X40, 1GDS, NH, STR-SW. Single-Ended Slider. Vascular graftZ-1951-2024 · DYF | Atrium Medical Corporation | Recall | Jun 4, 2024FDA classification date |
| ADVANTA VXT, 5X50, 1GDS, NH, STR-SW. Single-Ended Slider. Vascular graftZ-1954-2024 · DYF | Atrium Medical Corporation | Recall | Jun 4, 2024FDA classification date |
| ADVANTA VXT, 5X70, 1GDS, NH, STR-SW. Single-Ended Slider. Vascular graftZ-1958-2024 · DYF | Atrium Medical Corporation | Recall | Jun 4, 2024FDA classification date |
| ADVANTA VXT, 5X40, 1GDS, FH, STR-SW. Single-Ended Slider GDS. Vascular graftZ-1962-2024 · DYF | Atrium Medical Corporation | Recall | Jun 4, 2024FDA classification date |
| ADVANTA VXT, 5X50, 1GDS, FH, STR-SW. Single-Ended Slider GDS. Vascular graftZ-1964-2024 · DYF | Atrium Medical Corporation | Recall | Jun 4, 2024FDA classification date |
| ADVANTA VXT, 4-6X45, 1GDS, NH, TPR-SW. Single-Ended Slider GDS. Vascular graftZ-1993-2024 · DYF | Atrium Medical Corporation | Recall | Jun 4, 2024FDA classification date |
| ADVANTA VXT, 4-7X45, 1GDS, NH, TPR-SW. Single-Ended Slider GDS. Vascular graftZ-1994-2024 · DYF | Atrium Medical Corporation | Recall | Jun 4, 2024FDA classification date |
| ADVANTA VXT, 5-8X45, 1GDS, NH, TPR-SW. Single-Ended Slider GDS. Vascular graftZ-1995-2024 · DYF | Atrium Medical Corporation | Recall | Jun 4, 2024FDA classification date |
| ADVANTA VXT, 4-7X70, 1GDS, NH, TPR-SW. Single-Ended Slider GDS. Vascular graftZ-1996-2024 · DYF | Atrium Medical Corporation | Recall | Jun 4, 2024FDA classification date |
| ADVANTA VXT, 4-7X45, 2GDS, NH, TPR-SW. Single-Ended Slider GDS. Vascular graftZ-1997-2024 · DYF | Atrium Medical Corporation | Recall | Jun 4, 2024FDA classification date |
| ADVANTA VXT, 4-6X45, 1GDS, CH, TPR-SW. Single-Ended Slider GDS. Vascular graftZ-1998-2024 · DYF | Atrium Medical Corporation | Recall | Jun 4, 2024FDA classification date |
| ADVANTA VXT, 4-7X45, 1GDS, CH, TPR-SW. Single-Ended Slider GDS. Vascular graftZ-1999-2024 · DYF | Atrium Medical Corporation | Recall | Jun 4, 2024FDA classification date |
| ADVANTA VXT, 4-7X80, 1GDS, FH, TPR-TW. Single-Ended Slider GDS. Vascular graftZ-2000-2024 · DYF | Atrium Medical Corporation | Recall | Jun 4, 2024FDA classification date |
| ADVANTA VXT, 5-8X80, 1GDS, FH, TPR-TW. Single-Ended Slider GDS. Vascular graftZ-2001-2024 · DYF | Atrium Medical Corporation | Recall | Jun 4, 2024FDA classification date |
| Advanta VS Grafts <6mm Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.Z-2309-2013 · DYF | Atrium Medical Corporation | Recall | Sep 30, 2013FDA classification date |
| Advanta SuperSoft Grafts <6mm Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.Z-2312-2013 · DYF | Atrium Medical Corporation | Recall | Sep 30, 2013FDA classification date |
| Advanta VXT Grafts <6mm Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.Z-2313-2013 · DYF | Atrium Medical Corporation | Recall | Sep 30, 2013FDA classification date |
| IMPRA CARBOFLO EPTFE VASCULAR GRAFTSK004012 · DYF | Impra, Inc. | 510(k) | May 14, 2001FDA decision date |
| ADVANTA SUPER SOFT GRAFTK000504 · DYF | Atrium Medical Corp. | 510(k) | Mar 1, 2000FDA decision date |
| ADVANTA GRAFT (<6MM)K992958 · DYF | Atrium Medical Corp. | 510(k) | Oct 1, 1999FDA decision date |
| PTFE RINGED GORE-TEX VASCULAR GRAFTK991683 · DYF | W. L. Gore & Associates, Inc. | 510(k) | Sep 8, 1999FDA decision date |
| ADVANTA GRAFTK992441 · DYF | Atrium Medical Corp. | 510(k) | Aug 20, 1999FDA decision date |
| PERMA-PASS VASCULAR GRAFT, 5T GRAFT,MODEL 31451K984183 · DYF | Possis Medical, Inc. | 510(k) | Feb 1, 1999FDA decision date |
| DISTAFLO BYPASS GRAFTK983769 · DYF | Impra, Inc. | 510(k) | Dec 15, 1998FDA decision date |
| VENAFLO PTFE VASCULAR GRAFT, VENAFLO GRAFT WITH CARBON, VENAFLO VASCULAR GRAFTK981076 · DYF | Impra, Inc. | 510(k) | May 7, 1998FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.